The impact of neflamapimod on neurofilament light levels will be examined in a study of approximately 35 patients with ALS, ...

CD25 expression has long been recognized as an adverse prognostic marker in acute leukemias including acute myeloid leukemia ...

Dermatomyositis is a rare autoimmune disease that typically affects the skin, muscle and respiratory system. Patients with dermatomyositis usually require prompt treatment with intense ...

Background Concomitant metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in patients with chronic ...

Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed ...

The biotech company secured investigational new drug clearance from US regulators to begin human testing of its GNTbm-38 ...

Cells in our immune system are best known for providing security against external invaders such as bacteria and viruses. These immune cells also guard against internal threats, including cancerous ...

Scientists have uncovered a crucial weakness in the malaria parasite that could open the door to new treatments. Researchers identified a protein called Aurora-related kinase 1 (ARK1) that acts like a ...

Additional data from ADAPT SERON – the largest study of patients with gMG who do not have detectable AChR-Ab – demonstrate VYVGART’s efficacy and safety across subtypes New biomarker analysis, ...

Researchers identified invasive early disseminated cancer cells and immunosuppressive macrophage signaling that promote ...

A live link to the presentation will be located under “ Events ” in the Investors section of the Company’s website at www.actuatetherapeutics.com. A replay of the webcast will be available on ...

Explore the latest breakthrough in malaria drugs targeting a unique protein essential for the parasite's survival and transmission.